GroftSC. Orphan drug development in the United States. CPJ, 1985; 118(5):219-222
4.
LaRussoM, Gallego-PérezDF, Abadía-BarreroCE. Untimely care: How the modern logics of coverage and medicine compromise children's health and development. Soc Sci Med, 2023; 319:114962; doi: 10.1016/j.socscimed.2022.114962
5.
Luna. Uniting for the Common Good. 2023. Available from: https://www.lunadna.com/ [Last accessed: August8, 2023].
6.
MolinerAM, WaligoraJ. The European Union policy in the field of rare diseases. Adv Exp Med Biol, 2017; 1031:561-587; doi: 10.1007/978-3-319-67144-4_30
O'DorSL, HomayounS, DownerOM, et al.A survey of demographics, symptom course, family history, and barriers to treatment in children with pediatric acute-onset neuropsychiatric disorders and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections. J Child Adolesc Psychopharmacol, 2022; 32(9):476-487; doi: 10.1089/cap.2022.0063
9.
SwedoSE, LeonardHL, GarveyM, et al.Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry, 1998; 155(2):264-271; doi: 10.1176/ajp.155.2.264. Erratum in: Am J Psychiatry 1998;155(4):578.
10.
The Louisa Adelynn Johnson Fund for Complex Disease. 2023. Available from: www.tlajfundforcomplexdisease.com [Last accessed: August 8, 2023].
11.
TrifilettiR, LachmanHM, ManusamaO, et al.Identification of ultra-rare genetic variants in pediatric acute onset neuropsychiatric syndrome (PANS) by exome and whole genome sequencing. Sci Rep, 2022; 12(1):11106; doi: 10.1038/s41598-022-15279-3
12.
WeatherallDJ. Single gene disorders or complex traits: Lessons from the thalassaemias and other monogenic diseases. BMJ, 2000; 321(7269):1117-1120; doi: 10.1136/bmj.321.7269.1117
13.
WilburC, BitnunA, KronenbergS, et al.PANDAS/PANS in childhood: Controversies and evidence. Paediatr Child Health, 2019; 24(2):85-91; doi: 10.1093/pch/pxy145
